Gender differences in schizophrenia

Estrogen Effects in Psychiatric Disorders

Volumn , Issue , 2005, Pages 53-94

  Häfner, Heinz ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 61849172132     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-211-27063-9_3     Document Type: Chapter

References (118)

1. Albus M, Maier W (1995) Lack of gender differences in age at onset in familial schizophrenia. Schizophr Res 18: 51-57.
2. an der Heiden W, Krumm B, Müller S, Weber I, Biehl H, Schäfer M (1995) Mannheimer Langzeitstudie der Schizophrenie. Nervenarzt 66: 820-827.
3. an der Heiden W, Krumm B, Müller S, Weber I, Biehl H, Schäfer M (1996) Eine prospektive Studie zum Langzeitverlauf schizophrener Psychosen: Ergebnisse der 14-Jahres-Katamnese. ZMP 5: 66-75.
4. Andreasen NC (1983) The scale for the assessment of negative symptoms (SANS). University of Iowa, Iowa City.
5. Andreasen NC, Ehrhardt JC, Swayze VW, Alliger RJ, Yuh WTC, Cohen G, Ziebell S (1990) Magnetic resonance imaging of the brain in schizophrenia: The patho-physiologic significance of structural abnormalities. Arch Gen Psychiatry 47: 35-44.
6. Angermeyer MC, Kühn L (1988) Gender differences in age at onset of schizophrenia. Eur Arch Psychiatry Neurol Sci 237: 351-364.
7. Angermeyer MC, Kühn L, Goldstein JM (1990) Gender and the course of schizophrenia: Differences in treated outcomes. Schizophr Bull 16: 293-307.
8. APA - American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders. 3rd, revised ed. American Psychiatric Association, Washington DC.
9. APA - American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th, revised ed. American Psychiatric Association, Washington, DC.
10. Biehl H, Maurer K, Jablensky A, Cooper JE, Tomov T (1989) The WHO Psychological Impairments Rating Schedule (WHO/PIRS). I. Introducing a new instrument for rating observed behaviour and the rationale of the psychological impairment concept. Br J Psychiatry 155: 68-70.
11. Biehl H, Maurer K, Schubart C, Krumm B, Jung E (1986) Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics - results of a prospective 5-year follow-up study. Eur Arch Psychiatry Neurol Sci 236: 139-147.
12. Bland RC (1977) Demographic aspects of functional psychoses in Canada. Acta Psychiatr Scand 55: 369-380.
13. Bogerts B, Ashtari M, Degreef G, Alvis JMJ, Bilder RM, Lieberman JA (1990) Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res Neuroimag 35: 1-13.
14. Cannon TC, Mednick SA (1993) The schizophrenia high-risk project in Copenhagen: Three decades of progress. Acta Psychiatr Scand 370 (Suppl): 33-47.
15. Cannon TD, Mednick SA, Parnas J, Schulsinger F, Praestholm J, Vestergaard A (1993) Developmental brain abnormalities in the offspring of schizophrenic mothers: I. Contributions of genetic and perinatal factors. Arch Gen Psychiatry 50: 551-564.
16. Castle DJ (1999) Gender and age at onset in schizophrenia. In: Howard R, Rabins P, Castle D (eds) Late onset schizophrenia. Wrightson Biomedical, Hampshire, 147-164.
17. Castle DJ (2000) Women and schizophrenia: An epidemiological perspective. In: Castle DJ, McGrath J, Kulkarni J (eds) Women and schizophrenia. Cambridge University Press, Cambridge, 19-34.
18. Castle DJ, Wessely S, Murray RM (1993) Sex and schizophrenia: effects of diagnostic stringency, and association with premorbid variables. Br J Psychiatry 162: 658-664.
19. Choquet M, Ledoux S (1994) Epidémiologie et adolescence. In: Confrontations psychiatriques, vol 27 (no 35) Rhone-Poulenc Rorer Specia, Paris, 287-309.
20. Crow TJ, Done DJ, Sacker A (1995) Birth cohort study of the antecedents of psychosis: ontogeney as witness to phylogenetic origins. In: Häfner H, Gattaz WF (eds) Search for the causes of schizophrenia, vol III. Springer, Berlin Heidelberg, 3-20.
21. Dalton K (1959) Menstruation and acute psychiatric illness. Br Med J 1: 148-149.
22. DeLisi LE, Bass N, Boccio A, Shilds G, Morganti C, Vita A (1994) Age of onset in familial schizophrenia. Arch Gen Psychiatry 51: 334-335.
23. DiPaolo T, Falardeau P (1985) Modulation of brain and pituitary dopamine receptors by estrogens and prolactin. Progr Neuro-Psychopharmacol Biol Psychiatry 9: 473-480.
24. Döpfner M, Pluck J, Berner W, Fegert JM, Huss M, Lenz K, Schmeck K, Lehmkuhl U, Poustka F, Lehmkuhl G (1997) Psychische Auffälligkeiten von Kindern und Jugendlichen in Deutschland - Ergebnisse einer repräsentativen Studie: Methodik, Alters-, Geschlechts- und Beurteilereffekte (Mental disturbances in children and adolescents in Germany. Results of a representative study: Age, gender and rater effects). Z Kinder Jugendpsychiatr Psychother 25: 218-33.
25. Earls F (1987) Sex differences in psychiatric disorders: origins and developmental influences. Psychiatr Dev 1: 1-23.
26. Endo M, Daiguji M, Asano Y, Yanashita I, Lakahashi S (1978) Periodic psychosis occurring in association with the menstrual cycle. J Clin Psychiatry 39: 456-461.
27. Erlenmeyer-Kimling L, Kestenbaum C, Bird H, Hilldoff U (1984) Assessment of the New York high-risk project subjects in sample A who are now clinical deviants. In: Watt N, Anthony N, Wynne EJ, Rolf LC (eds) Children at risk for schizophrenia: A longitudinal perspective. Cambridge University Press, Cambridge.
28. Erlenmeyer-Kimling L, Cornblatt BA, Rock D, Roberts S, Bell M, West A (1993) The New York high-risk project: Anhedonia, attentional deviance, and psychopathology. Schizophr Bull 19: 141-153.
29. Felthous AR, Robinson DB, Conroy RW (1980) Prevention of recurrent menstrual psychosis by an oral contraceptive. Am J Psychiatry 137: 245-246.
30. Fields JZ, Gordon JH (1982) Estrogen inhibits the dopaminergic supersensitivity induced by neuroleptics. Life Sciences 30: 229-234.
31. Fink G (1995) The psychoprotective action of estrogen is mediated by central serotonergic as well as dopaminergic mechanisms. In: Takada A, Curzon G (eds) Serotonin in the central nervous system and periphery. Elsevier Science, The Netherlands, 175-187.
32. Fink G, Sumner B, McQueen JK, Wilson H, Rose R (1998) Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol 25: 764-765.
33. Fitzgerald P, Seeman MV (2000) Women and schizophrenia: Treatment implications. In: Castle DJ, McGrath J, Kulkarni J (eds) Women and schizophrenia. Cambridge University Press, Cambridge, 95-110.
34. Flaum M, Swayze VW, O'Leary DS, Yuh WT, Ehrhardt JC, Arndt S, Andreasen NC (1995) Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia. Am J Psychiatry 152: 704-714.
35. Gattaz WF, Behrens S, De Vrie J, Häfner H (1992) Östradiol hemmt Dopamin-vermittelte Verhaltensweisen bei Ratten - ein Tiermodell zur Untersuchung der geschlechtsspezifischen Unterschiede bei der Schizophrenie. Fortschr Neurol Psychiatr 60: 8-16.
36. Goldberg TE, Gold JM; Torrey EF, Weinberger DR (1995) Lack of sex differences in the neuropsychological performance of patients with schizophrenia. Am J Psychiatry 152: 883-888.
37. Goldstein JM (1988) Gender differences in the course of schizophrenia. Am J Psychiatry 145: 684-689.
38. Goldstein JM (1993) Impact of sampling biases in explaining discrepancies in studies on gender and schizophrenia: A reply. Schizophr Bull 19: 9-14.
39. Goldstein JM (1995a) The impact of gender on understanding the epidemiology of schizophrenia. In: Seeman MV (ed) Gender and psychopathology. American Psychiatric Press, Washington DC, 159-199.
40. Goldstein JM (1995b) Gender and the famial transmission of schizophrenia. In: Seeman MV (ed) Gender and psychopathology. American Psychiatric Press, Washington DC.
41. Goldstein JM (1996) Sex and brain abnormalities in schizophrenia: fact or fiction? Harvard Rev Psychiatry 4: 110-115.
42. Goldstein JM, Lewine RRJ (2000) Overview of sex differeces in schizophrenia: where have we been and where do we go from here? In: Castle DJ, McGrath J, Kulkarni J (eds) Women and schizophrenia. Cambridge University Press, Cambridge, 111-143.
43. Gur RE, Gur RC (1990) Gender differences in regional cerebral blood flow. Schizophr Bull 16: 247-254.
44. Gur RC, Mozley LH, Mozley PD, Resnick SM, Karp JS, Alavi A, Arnold SE, Gur RE (1995) Sex differences in regional cerebral glucose metabolism during a resting state. Science 267: 528-531.
45. Häfner H (1996) The epidemiology of onset and early course of schizophrenia. In: Häfner H, Wolpert EM (eds) New research in psychiatry. Hogrefe and Huber Publishers, Seattle Toronto, 33-60.
46. Häfner H (1998) Ist es einzig die Krankheit? In: Möller H-J, Müller N (eds) Schizophrenie - Moderne Konzepte zu Diagnostik, Pathogenese und Therapie. Springer, Wien, 37-59.
47. Häfner H (2000) Gender differences in schizophrenia. In: Frank E (ed) Gender and its effects on psychopathology. American Psychopathological Association Series. American Psychiatric Press, Washington DC, 187-228.
48. Häfner H, an der Heiden W (1997) Epidemiology of schizophrenia. Can J Psychiatry 42: 139-151.
49. Häfner H, an der Heiden W (1999) The course of schizophrenia in the light of modern follow-up studies: The ABC and WHO studies. Eur Arch Psychiatry Clin Neurosci 249 (Suppl 4): IV/14-IV/26.
50. Häfner H, Nowotny B (1995) Epidemiology of early-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 245: 80-92.
51. Häfner H, Behrens S, de Vry J, Gattaz WF, Löffler W, Maurer K, Riecher-Rössler A (1991) Warum erkranken Frauen später an Schizophrenie? Nervenheilkunde 10: 154-163.
52. Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, Fätkenheuer B, Löffler W, an der Heiden W (1992) IRAOS: An instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 6: 209-223.
53. Häfner H, Maurer K, Löffler W, Riecher-Rössler A (1993a) The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 162: 80-86.
54. Häfner H, Riecher-Rössler A, an der Heiden W, Maurer K, Fätkenheuer B, Löffler W (1993b) Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 23: 925-940.
55. Häfner H, Maurer K, Löffler W, Bustamante S, an der Heiden W, Riecher-Rössler A, Nowotny B (1995) Onset and early course of schizophrenia. In: Häfner H, Gattaz WF (eds) Search for the causes of schizophrenia, vol III. Springer, Berlin Heidelberg, 43-66.
56. Häfner H, Maurer K, Löffler W, Nowotny B (1996) Der Frühverlauf der Schizophrenie. ZMP 5: 22-31.
57. Häfner H, Hambrecht M, Löffler W, Munk-Jorgensen P, Riecher-Rössler A (1998a) Is schizophrenia a disorder of all ages? A comparison of first episodes and early course over the life-cycle. Psychol Med 28: 351-365.
58. Häfner H, an der Heiden W, Behrens S, Gattaz WF, Hambrecht M, Löffler W, Maurer K, Munk-Jörgensen P, Nowotny B, Riecher-Rössler A, Stein A (1998b) Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull 24: 99-113.
59. Häfner H, Löffler W, Maurer K, Riecher-Rössler A, Stein A (1999a) Interview für die retrospektive Erfassung des Erkrankungsbeginns und -verlaufs bei Schizophrenie und anderen Psychosen. Huber, Bern (English translation 2003).
60. Häfner H, Maurer K, Löffler W, an der Heiden W, Stein A, Könnecke R, Hambrecht M (1999b) Onset and prodromal phase and determinants of the course. In: Gattaz WF, Häfner H (eds) Search for the causes of schizophrenia, Vol IV: Balance of the century. Springer, Berlin Heidelberg/Steinkopff, Darmstadt, 35-58.
61. Hallonquist JD, Seeman MV, Lang M, Rector NA (1993) Variation in symptom severity over the menstural cycle of schizophrenics. Biol Psychiatry 33: 207-209.
62. Hambrecht M, Maurer K, Sartorius N, Häfner H (1992) Transnational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders. Eur Arch Psychiatry Clin Neurosci 242: 6-12.
63. Hambrecht M, Riecher-Rössler A, Fätkenheuer B, Louza MR, Häfner H (1994) Higher morbidity risk for schizophrenia in males: Fact or fiction? Compr Psychiatry 35: 39-49.
64. Harrison G, Croudace T, Mason P, Glazebrook C, Medley I (1996) Predicting the long-term outcome of schizophrenia. Psychol Med 26: 697-705.
65. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G (1994) One hundred years of schizophrenia: A meta-Analysis of the outcome literature. Am J Psychiatry 151: 1409-1416.
66. Hruska RE (1986) Evaluation of striatal dopamine receptors by estrogen: Dose and time studies. J Neurochem 47: 1908-1915.
67. Isohanni M, Rantakallio P, Jones P, Järvelin M-R, Isohanni I, Mäkikyrö T, Moring J (1998a) The predictors of schizophrenia in the 1966 Northern Finland Birth Cohort Study. Schizophr Res 29: 11.
68. Isohanni M, Järvelin M-R, Nieminen P, Jones P, Rantakallio P, Jokelainen J, Isohanni M (1998b) School performance as a predictor of psychiatric hospitalization in adult life. A 28-year follow-up in the Northern Finland 1966 Birth Cohort. Psychol Med 28: 967-974.
69. Jablensky A (1995) Schizophrenia: The epidemiological horizon. In: Hirsch SR, Weinberger DR (eds) Schizophrenia. Blackwell Science, Oxford, 206-252.
70. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A (1992) Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychological Medicine Monograph (Suppl 20) Cambridge University Press, Cambridge.
71. Jones PB, Murray RM, Rodgers B (1995) Childhood risk factors for adult schizophrenia in a general population birth cohort at age 43 years. In: Mednick SA, Hollister JM (eds) Neural development in schizophrenia. Plenum Press, New York, 151-176.
72. Jung E, Krumm B, Biehl H, Maurer K, Bauer-Schubart C (1989) DAS - Mannheimer Skala zur Einschätzung sozialer Behinderung. Beltz, Weinheim.
73. Könnecke R, Häfner H, Maurer K, Löffler W, an der Heiden W (2000) Main risk factors for schizophrenia: Increased familial loading and pre- And perinatal complications antagonize the protective effect of oestrogen in women. Schizophr Res 44: 81-93.
74. Kraak B, Nord-Rüdiger D (1989) Der Fragebogen zu Lebenszielen und zur Lebenszufriedenheit (FLL). Hogrefe, Göttingen.
75. Kraepelin E (1909-1915) Psychiatrie, vol 1-4, 8th ed. Barth, Leipzig.
76. Kretschmer E (1921) Körperbau und Charakter, 25th ed. Springer, Heidelberg.
77. Kulkarni J, de Castella A, Smith D, Taffe J, Keks N, Copolov D (1996a) A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res 20: 247-252.
78. Kulkarni J, Gostt K, de Castella A (1996b) The menstrual cycle in women with schizophrenia. Schizophr Res 18: 254.
79. Kulkarni J, de Castella A, Taffe J, Burger H, Reidel A (1999) Clinical estrogen trials in patients with schizophrenia. Curr Opin Psychiatry 12 (Suppl 1): 184-185.
80. Kulkarni J, de Castella A, Downey M, White S, Taffe J, Fitzgerald P, Burger H (2002) Results of two controlled studies on estrogen: Avenue to neuroprotection in schizophrenia. In: Häfner H (ed) Risk and protective factors in schizophrenia. Steinkopff, Darmstadt, 271-282.
81. Lauriello J, Hoff A, Wieneke MH, Blankfeld H, Faustman WO, Rosenbloom M, DeMent S, Sullivan EV, Lim KO, Pfefferbaum A (1997) Similar extent of brain dysmorphology in severly ill women and men with schizophrenia. Am J Psychiatry 154: 819-825.
82. Leboyer M, Filteau M-J, Jay M, Campion D, Rochert T, D'Amato T, Feingold J, Des Lauries A, Widlöcher D (1992) No gender effect on age of onset in familial schizophrenia? Am J Psychiatry 149: 1409.
83. Lehman AF (1983b) The effects of psychiatric symptoms on quality of life assessments among the chronic mentally ill. Evaluation and Program Planning 6: 143-151.
84. Lehman AF (1983a) The well-being of chronic mental patients. Arch Gen Psychiatry 40: 369-375.
85. Lewine RJ (1980) Sex differences in age of symptom onset and first hospitalization in schizophrenia. Am J Orthopsychiatry 50: 316-322.
86. Lewine RRJ (1988) Gender and schizophrenia. In: Nasrallah HA (ed) Handbook of schizophrenia, vol 3. Elsevier, Amsterdam, 389-397.
87. Lewine RRJ, Seeman MV (1995) Gender, brain and schizophrenia: Anatomy of differences/differences of anatomy. In: Seeman MV (ed) Gender and psychopathology. American Psychiatric Press, Washington DC, 131-158.
88. Lewine RRJ, Burback D, Meltzer HY (1984) Effect of diagnostic criteria on the ratio of male to female schizophrenic patients. Am J Psychiatry 141: 84-87.
89. Lewine R, Haden C, Caudle J, Shurett R (1997) Sex-onset effects on neuropsychological function in schizophrenia. Schizophr Bull 23: 51-61.
90. Loranger AW (1984) Sex difference in age of onset of schizophrenia. Arch Gen Psychiatry 41: 157-161.
91. Löffler W, Häfner H, Fätkenheuer B, Maurer K, Riecher-Rössler A, Lützhøft J, Skadhede S, Munk- Jørgensen P, Strömgren E (1994) Validation of Danish case register diagnosis for schizophrenia. Acta Psychiatr Scand 90: 196-203.
92. Maccoby EE, Jacklin CN (1974) The psychology of sex differences. Stanford University Press, Stanford.
93. McEwen BS, Biegon A, Rainbow TC, Paden C. Snyder L. DeGroff V (1981) The interaction of estrogens with intracellular receptors and with putative neurotransmitter receptors: Implications for the mechanisms of activation of regulation of sexual behaviour and ovulaton. In: Fuxe K, Gustafsson JA, Wetterberg L (eds) Steroid hormone regulation of the brain. Pergamon Press, New York, 15-29.
94. Mendelson WB, Gillin JC, Wyatt RJ (1977) Sexual physiology and schizophrenia. Acta Scientifica Venezolana 28: 417-425.
95. Mueser KT, Bellack AS, Morrison RL, Wixted JT (1990) Social competence in schizophrenia: premorbid adjustment, social skill, and domains of functioning. J Psychiatr Res 24: 51-63.
96. Opjordsmoen S (1991) Long-term clinical outcome of schizophrenia with special reference to gender differences. Acta Psychiatr Scand 83: 307-313.
97. Parnas J, Cannon TD, Jacobsen B, Schulsinger H, Schulsinger F, Mednick SA (1993) Lifetime DSM-IIIR diagnostic outcomes in offspring of schizophrenic mothers: Results from the Copenhagen High-Risk Study. Arch Gen Psychiatry 50: 707-714.
98. Reite M, Teale P, Goldstein L, Whalen J, Linnville S (1989) Late auditory magnetic sources may differ in the left hemisphere of schizophrenic patients. Arch Gen Psychiatry 46: 565-572.
99. Reite M, Cullum CM, Stocker J, Teale P, Kozora E (1993) Neuropsychological test performance and MEG-based brain lateralization: Sex differences. Br Res Bull 32: 325-328.
100. Richman N, Stevenson J, Graham P (1982) Preschool to school: A behavioural study. Academic Press, London.
101. Riecher-Rössler A, Häfner H (1993) Schizophrenia and oestrogens - is there an association? Eur Arch Psychiatry Clin Neurosci 242: 323-328.
102. Riecher-Rössler A, Häfner H, Stumbaum M, Maurer K, Schmidt R (1994a) Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 20: 203-214.
103. Riecher-Rössler A, Häfner H, Dütsch-Strobel A, Oster M, Stumbaum M, van Gülick- Bailer M, Löffler W (1994b) Further evidence for a specific role of estradiol in schizophrenia? Biol Psychiatry 36: 492-495.
104. Salokangas RKR, Stengard E, Räkköläinen V, Kaljonen IHA (1987) New schizophrenic patients and their families (English summary). In: Reports of Psychiatria Fennica 78. Foundation for Psychiatric Research in Finland, 119-216.
105. Seeman M (1983) Interaction of sex, age and neuroleptic dose. Compr Psychiatry 24: 125-128.
106. Seeman MV, Lang M (1990) The role of estrogens in schizophrenia gender differences. Schizophr Bull 16:185-194.
107. Seeman M, Cohen R (1999) Puberty and schizophrenia. In: Lopéz-Ibor JL, Sartorius N, Gaebel W, Haasen C (eds) Psychiatry on new thresholds. Abstracts of the 11th World Congress of Psychiatry, Hamburg, Germany, 6-11 August, 1999, vol I. (Curr Opin Psychiatry 12 [Suppl 1]).
108. Shughrue PJ, Lane MV, Merchenthaler I (1997) Comparative distribution of estrogen receptor and X and B MRNA in the rat central nervous system. J Compr Neurol 388: 507-525.
109. Sumner BEH, Fink G (1995) Oestradiol-17ß in its positive feedback mode significantly increases 5-HT2a receptor density in the frontal, cingulate and piriform cortex of the female rat. J Physiology 483: 52.
110. Sumner BEH, Grant KE, Rosie R, Hegele-Hartung Ch, Fritzemeier K-H, Fink G (1999) Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine2A receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Mol Brain Res 73: 119-128.
111. Walker EF, Weinstein J, Baum K, Neumann CS (1995) Antecedents of schizophrenia: Moderating effects of development and biological sex. In: Häfner H, Gattaz WF (eds) Search for the causes of schizophrenia, vol III. Springer, Berlin Heidelberg, 21-42.
112. Watt NF, Grubb TW, Erlenmeyer-Kimling L (1984) Social, emotional, and intellectual behavior at school among children at high risk for schizophrenia. In: Watt NF, Anthony J, Wynne LC, Rolf LC (eds) Children at high risk for schizophrenia. Cambridge University Press, London, 212-226.
113. Weber I (1996) Lebenszufriedenheit einer Kohorte Schizophrener 15, 5 Jahre nach stationärer Aufnahme. Doctoral thesis, Mannheim Faculty of Clinical Medicine of the Ruprecht Karls University of Heidelberg.
114. Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Mark M, Nahon D, Davidson M (2000) Gender differences in premorbid cognitive performance in a national cohort of schizophrenic patients. Schizophr Res 45: 185-190.
115. WHO-World Health Organization (1980) Follow-Up History Schedule (WHO/FU-HSD) Geneva.
116. WHO-World Health Organization (1988) Psychiatric Disability Assessment Schedule (WHO/DAS). WHO, Geneva.
117. Wing JK, Cooper JE, Sartorius N (1974) Measurement and classification of psychiatric symptoms: An instruction manual for the PSE and CATEGO program. Cambridge University Press, London.
118. Woolley CS, McEwen BS (1994) Estradiol regulates hippocampal dendritic spine density via an N-Methyl-D-Aspartate receptor-dependent mechanism. J Neurosci 14: 7680-7687.